Send the following on WhatsApp
Continue to ChatTakeda announces positive results for mezagitamab in Phase 2 ITP study https://business-news-today.com/takeda-announces-positive-results-for-mezagitamab-in-phase-2-itp-study/
Takeda announces positive results for mezagitamab in Phase 2 ITP study https://business-news-today.com/takeda-announces-positive-results-for-mezagitamab-in-phase-2-itp-study/